Fresenius announces decision on biotechnology business
Fresenius has decided to focus on its four established business segments Fresenius Medical Care, Fresenius Kabi, Freseni…
Fresenius has decided to focus on its four established business segments Fresenius Medical Care, Fresenius Kabi, Freseni…
The Belgian Ministry of Social Affairs and Public Health has added the trifunctional antibody Removab® (catumaxomab) fro…
The European Commission has broadened the existing approval of Fresenius Biotech's antibody Removab® (catumaxomab) to tr…